Pharmacokinetic–Pharmacometabolomic Approach in Early-Phase Clinical Trials: A Way Forward for Targeted Therapy in Type 2 Diabetes

Pharmacometabolomics in early phase clinical trials demonstrate the metabolic profiles of a subject responding to a drug treatment in a controlled environment, whereas pharmacokinetics measure the drug plasma concentration in human circulation. Application of the personalized peak plasma concentrati...

Descripción completa

Detalles Bibliográficos
Autores principales: Tee, Khim Boon, Ibrahim, Luqman, Hashim, Najihah Mohd, Saiman, Mohd Zuwairi, Zakaria, Zaril Harza, Huri, Hasniza Zaman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231303/
https://www.ncbi.nlm.nih.gov/pubmed/35745841
http://dx.doi.org/10.3390/pharmaceutics14061268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231303/
https://www.ncbi.nlm.nih.gov/pubmed/35745841
http://dx.doi.org/10.3390/pharmaceutics14061268

Ejemplares similares